Making Cervical Cancer Vaccines Widely Available in Developing Countries: Cost and Financing Issues
Financing the human papillomavirus (HPV) vaccine and mobilizing resources to support new delivery mechanisms will constitute some of the most significant challenges to achieving widespread HPV vaccination in the developing world. This brief summarizes the main findings of the longer research publication, HPV Vaccine Adoption in Developing Countries: Cost and Financing Issues.
Publication date: December 2007
Making Cervical Cancer Vaccines Widely Available in Developing Countries: Cost and Financing Issues
Hard copies are not available.